Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Sep 23
 +0.35 / +0.75%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-0.21% 3 years+11.84%
3 months+10.39% 5 years+19.31%
1 year-7.70% Since inception+13.83%
Data through 09/24/2016

Quote Details

Previous close$46.56
Open day’s range46.53 – 47.10
Net asset value (NAV)46.93 (09/23/2016)
Daily volume259,669
Average volume (3 months)153,838
Data as of 7:59pm ET, 09/23/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+19.31%+15.32%
Expense Gross exp ratio0.35%0.48%
Risk 5 year sharpe ratio0.871.16
Net assets$511.6M$1.1B
Average market cap$9.1B$37.2B
Average P/E27.720.2
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
ENDP Endo International PLC5.54%
MNK Mallinckrodt Plc5.50%
MRK Merck4.87%
ZTS Zoetis Inc4.76%
HZNP Horizon Pharma PLC4.64%
LLY Eli Lilly and Co4.64%
JNJ Johnson & Johnson4.50%
-- 4.46%
PFE Pfizer4.35%
AGN Allergan4.29%

Search for Jobs